(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of EGLN3 mRNA] CTD PMID:31150632 (-)-alpha-phellandrene increases expression ISO RGD:732652 6480464 alpha phellandrene results in increased expression of EGLN3 mRNA CTD PMID:25075043 (1->4)-beta-D-glucan multiple interactions ISO RGD:732653 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EGLN3 mRNA CTD PMID:36331819 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of EGLN3 protein CTD PMID:17337753 1,2-dimethylhydrazine multiple interactions ISO RGD:732653 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of EGLN3 mRNA CTD PMID:22206623 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of EGLN3 mRNA CTD PMID:30723492 17alpha-ethynylestradiol multiple interactions ISO RGD:732653 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EGLN3 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of EGLN3 mRNA CTD PMID:15576828 , PMID:15901920 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of EGLN3 mRNA CTD PMID:16079270 17beta-estradiol multiple interactions ISO RGD:732652 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of EGLN3 mRNA more ... CTD PMID:19619570 more ... 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of EGLN3 mRNA CTD PMID:32145629 17beta-estradiol increases expression ISO RGD:732653 6480464 Estradiol results in increased expression of EGLN3 mRNA CTD PMID:19484750 17beta-estradiol decreases expression ISO RGD:732652 6480464 Estradiol results in decreased expression of EGLN3 mRNA CTD PMID:20106945 more ... 17beta-estradiol increases expression ISO RGD:732652 6480464 Estradiol results in increased expression of EGLN3 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732653 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of EGLN3 mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of EGLN3 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732653 6480464 Tetrachlorodibenzodioxin affects the expression of EGLN3 mRNA CTD PMID:21570461 , PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:732652 6480464 Tetrachlorodibenzodioxin affects the expression of EGLN3 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of EGLN3 mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732653 6480464 Tetrachlorodibenzodioxin results in increased expression of EGLN3 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732652 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of EGLN3 mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:732652 6480464 Tetrachlorodibenzodioxin results in increased expression of EGLN3 mRNA CTD PMID:19619570 4,4'-sulfonyldiphenol increases expression ISO RGD:732653 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of EGLN3 mRNA CTD PMID:33297965 4-hydroxyphenyl retinamide increases expression ISO RGD:732653 6480464 Fenretinide results in increased expression of EGLN3 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression ISO RGD:732653 6480464 Fenretinide results in decreased expression of EGLN3 mRNA CTD PMID:28973697 acetamide increases expression EXP 6480464 acetamide results in increased expression of EGLN3 mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of EGLN3 mRNA CTD PMID:28959563 acrylamide decreases expression ISO RGD:732652 6480464 Acrylamide results in decreased expression of EGLN3 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO RGD:732652 6480464 Aflatoxin B1 affects the expression of EGLN3 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO RGD:732652 6480464 Aflatoxin B1 results in increased expression of EGLN3 mRNA CTD PMID:22100608 , PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of EGLN3 mRNA CTD PMID:23630614 , PMID:25378103 alendronic acid affects expression EXP 6480464 Alendronate affects the expression of EGLN3 mRNA CTD PMID:16079270 all-trans-retinoic acid increases expression ISO RGD:732652 6480464 Tretinoin results in increased expression of EGLN3 mRNA CTD PMID:33167477 alpha-phellandrene increases expression ISO RGD:732652 6480464 alpha phellandrene results in increased expression of EGLN3 mRNA CTD PMID:25075043 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of EGLN3 mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of EGLN3 mRNA CTD PMID:30779732 amphotericin B decreases expression ISO RGD:732652 6480464 Amphotericin B analog results in decreased expression of EGLN3 mRNA CTD PMID:28534445 andrographolide increases expression ISO RGD:732652 6480464 andrographolide results in increased expression of EGLN3 protein CTD PMID:27297870 arotinoid acid multiple interactions ISO RGD:732652 6480464 [4-(2-(5 more ... CTD PMID:34480604 Azaspiracid increases expression ISO RGD:732652 6480464 azaspiracid results in increased expression of EGLN3 mRNA CTD PMID:28939011 Bardoxolone methyl affects expression ISO RGD:732652 6480464 bardoxolone methyl affects the expression of EGLN3 mRNA CTD PMID:34480604 benazepril increases expression EXP 6480464 benazepril results in increased expression of EGLN3 mRNA CTD PMID:14871019 benzo[a]pyrene affects methylation ISO RGD:732652 6480464 Benzo(a)pyrene affects the methylation of EGLN3 intron CTD PMID:30157460 benzo[a]pyrene increases expression ISO RGD:732652 6480464 Benzo(a)pyrene results in increased expression of EGLN3 mRNA CTD PMID:32234424 benzo[a]pyrene increases methylation ISO RGD:732652 6480464 Benzo(a)pyrene results in increased methylation of EGLN3 exon, Benzo(a)pyrene results in increased methylation of EGLN3 promoter CTD PMID:27901495 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EGLN3 mRNA CTD PMID:18164116 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of EGLN3 mRNA CTD PMID:15901920 , PMID:25181051 bisphenol A increases expression ISO RGD:732653 6480464 bisphenol A results in increased expression of EGLN3 mRNA CTD PMID:32156529 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of EGLN3 mRNA CTD PMID:32145629 bortezomib multiple interactions ISO RGD:732652 6480464 [BRCA1 mutant form results in increased susceptibility to Bortezomib] which results in decreased expression of EGLN3 mRNA CTD PMID:25522274 cantharidin decreases expression ISO RGD:732653 6480464 Cantharidin results in decreased expression of EGLN3 mRNA CTD PMID:36907384 carbon nanotube decreases expression ISO RGD:732653 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases expression ISO RGD:732653 6480464 Nanotubes more ... CTD PMID:25554681 CHIR 99021 multiple interactions ISO RGD:732652 6480464 [4-(2-(5 more ... CTD PMID:34480604 choline multiple interactions ISO RGD:732653 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EGLN3 gene CTD PMID:20938992 cisplatin multiple interactions ISO RGD:732652 6480464 Cisplatin promotes the reaction [jinfukang results in increased expression of EGLN3 mRNA], jinfukang promotes the reaction [Cisplatin results in increased expression of EGLN3 mRNA] CTD PMID:27392435 cisplatin increases expression ISO RGD:732652 6480464 Cisplatin results in increased expression of EGLN3 mRNA CTD PMID:27392435 cobalt atom multiple interactions ISO RGD:732652 6480464 [tungsten carbide binds to Cobalt] which results in increased expression of EGLN3 mRNA, [tungsten carbide co-treated with Cobalt] results in increased expression of EGLN3 mRNA CTD PMID:18078969 , PMID:20105288 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of EGLN3 mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:732652 6480464 cobaltous chloride results in increased expression of EGLN3 mRNA CTD PMID:19376846 , PMID:20105288 copper atom multiple interactions ISO RGD:732652 6480464 [Chelating Agents binds to Copper] which affects the expression of EGLN3 mRNA, [Organoselenium Compounds binds to Copper] which results in increased expression of EGLN3 mRNA CTD PMID:25167922 , PMID:30911355 copper(0) multiple interactions ISO RGD:732652 6480464 [Chelating Agents binds to Copper] which affects the expression of EGLN3 mRNA, [Organoselenium Compounds binds to Copper] which results in increased expression of EGLN3 mRNA CTD PMID:25167922 , PMID:30911355 corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of EGLN3 mRNA CTD PMID:15755911 cortisol multiple interactions ISO RGD:732652 6480464 [4-(2-(5 more ... CTD PMID:34480604 cyclosporin A decreases expression ISO RGD:732652 6480464 Cyclosporine results in decreased expression of EGLN3 mRNA CTD PMID:20106945 more ... deguelin multiple interactions ISO RGD:732652 6480464 deguelin inhibits the reaction [Oxygen deficiency results in increased expression of EGLN3 mRNA] CTD PMID:22745725 diazinon increases methylation ISO RGD:732652 6480464 Diazinon results in increased methylation of EGLN3 gene CTD PMID:22964155 diazinon affects expression EXP 6480464 Diazinon affects the expression of EGLN3 mRNA CTD PMID:22546817 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of EGLN3 mRNA CTD PMID:22546817 diethyl maleate increases expression ISO RGD:732652 6480464 diethyl maleate results in increased expression of EGLN3 mRNA CTD PMID:34480604 diethylstilbestrol increases expression ISO RGD:732652 6480464 Diethylstilbestrol results in increased expression of EGLN3 mRNA CTD PMID:19371625 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of EGLN3 mRNA CTD PMID:37077353 dimethylselenide multiple interactions ISO RGD:732652 6480464 [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of EGLN3 mRNA CTD PMID:33656867 dinophysistoxin 1 increases expression ISO RGD:732652 6480464 dinophysistoxin 1 results in increased expression of EGLN3 mRNA CTD PMID:28939011 dioxygen increases expression ISO RGD:732653 6480464 Oxygen deficiency results in increased expression of EGLN3 mRNA CTD PMID:20880076 dioxygen increases expression ISO RGD:732652 6480464 Oxygen deficiency results in increased expression of EGLN3 mRNA CTD PMID:20042640 more ... dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of EGLN3 mRNA CTD PMID:23545307 dioxygen multiple interactions EXP 6480464 AQP3 protein promotes the reaction [Oxygen deficiency results in increased expression of EGLN3 mRNA] more ... CTD PMID:23545307 dioxygen multiple interactions ISO RGD:732652 6480464 deguelin inhibits the reaction [Oxygen deficiency results in increased expression of EGLN3 mRNA] CTD PMID:22745725 dorsomorphin multiple interactions ISO RGD:732652 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin decreases expression ISO RGD:732652 6480464 Doxorubicin results in decreased expression of EGLN3 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of EGLN3 mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:732653 6480464 epoxiconazole results in decreased expression of EGLN3 mRNA CTD PMID:35436446 fenthion decreases expression ISO RGD:732653 6480464 Fenthion results in decreased expression of EGLN3 mRNA CTD PMID:34813904 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of EGLN3 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:732653 6480464 [1 more ... CTD PMID:20938992 , PMID:22206623 folic acid decreases expression ISO RGD:732653 6480464 Folic Acid results in decreased expression of EGLN3 mRNA CTD PMID:25629700 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of EGLN3 mRNA CTD PMID:33387578 GW 4064 decreases expression ISO RGD:732653 6480464 GW 4064 results in decreased expression of EGLN3 mRNA CTD PMID:26655953 heparin multiple interactions EXP 6480464 Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of EGLN3 mRNA] CTD PMID:16401727 hydrogen peroxide multiple interactions ISO RGD:732652 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of EGLN3 protein CTD PMID:18951874 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of EGLN3 mRNA CTD PMID:21396975 iron atom increases expression EXP 6480464 Iron deficiency results in increased expression of EGLN3 mRNA CTD PMID:16629162 iron(0) increases expression EXP 6480464 Iron deficiency results in increased expression of EGLN3 mRNA CTD PMID:16629162 ivermectin decreases expression ISO RGD:732653 6480464 Ivermectin results in decreased expression of EGLN3 mRNA CTD PMID:28942281 ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of EGLN3 mRNA CTD PMID:37077353 L-ascorbic acid multiple interactions ISO RGD:732652 6480464 [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EGLN3 mRNA, [Quercetin co-treated with Ascorbic Acid] results in increased expression of EGLN3 mRNA CTD PMID:17639512 , PMID:34480604 L-ascorbic acid 2-phosphate multiple interactions ISO RGD:732652 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of EGLN3 mRNA CTD PMID:34480604 L-methionine multiple interactions ISO RGD:732653 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of EGLN3 gene CTD PMID:20938992 lead diacetate decreases expression ISO RGD:732653 6480464 lead acetate results in decreased expression of EGLN3 mRNA CTD PMID:22609695 lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of EGLN3 mRNA, Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of EGLN3 mRNA] CTD PMID:16401727 , PMID:16415329 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of EGLN3 mRNA CTD PMID:28801915 menadione decreases expression ISO RGD:732653 6480464 Vitamin K 3 results in decreased expression of EGLN3 mRNA CTD PMID:25270620 methamphetamine increases expression ISO RGD:732653 6480464 Methamphetamine results in increased expression of EGLN3 mRNA CTD PMID:36914120 methylmercury chloride increases expression ISO RGD:732652 6480464 methylmercuric chloride results in increased expression of EGLN3 mRNA CTD PMID:23179753 , PMID:26272509 methylmercury chloride decreases expression ISO RGD:732652 6480464 methylmercuric chloride results in decreased expression of EGLN3 mRNA CTD PMID:28001369 methylmercury chloride multiple interactions ISO RGD:732652 6480464 [NOG protein co-treated with methylmercuric chloride co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of EGLN3 mRNA CTD PMID:27188386 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO RGD:732653 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of EGLN3 mRNA CTD PMID:25566086 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO RGD:732653 6480464 MYBPC3 protein affects the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of EGLN3 mRNA] CTD PMID:25566086 N-methyl-4-phenylpyridinium decreases expression ISO RGD:732653 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of EGLN3 mRNA CTD PMID:17475336 , PMID:18069091 N-methyl-N-nitrosourea decreases expression ISO RGD:732653 6480464 Methylnitrosourea results in decreased expression of EGLN3 mRNA CTD PMID:25270620 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of EGLN3 mRNA CTD PMID:18164116 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of EGLN3 mRNA CTD PMID:19638242 N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of EGLN3 mRNA, Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of EGLN3 mRNA] CTD PMID:16401727 , PMID:16415329 nickel atom increases expression ISO RGD:732653 6480464 Nickel results in increased expression of EGLN3 mRNA CTD PMID:18922574 nickel dichloride increases expression ISO RGD:732652 6480464 nickel chloride results in increased expression of EGLN3 mRNA CTD PMID:21455298 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of EGLN3 mRNA CTD PMID:22110744 , PMID:22546817 okadaic acid increases expression ISO RGD:732652 6480464 Okadaic Acid results in increased expression of EGLN3 mRNA CTD PMID:28939011 organoselenium compound multiple interactions ISO RGD:732652 6480464 [Organoselenium Compounds binds to Copper] which results in increased expression of EGLN3 mRNA CTD PMID:25167922 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of EGLN3 mRNA CTD PMID:23665939 ozone increases expression ISO RGD:732653 6480464 Ozone results in increased expression of EGLN3 mRNA CTD PMID:31626304 paracetamol affects expression ISO RGD:732653 6480464 Acetaminophen affects the expression of EGLN3 mRNA CTD PMID:17562736 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:732653 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of EGLN3 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of EGLN3 mRNA CTD PMID:19162173 phenobarbital multiple interactions ISO RGD:732653 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of EGLN3 mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:732653 6480464 Phenobarbital results in increased expression of EGLN3 mRNA CTD PMID:19482888 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of EGLN3 mRNA CTD PMID:18158353 pirinixic acid decreases expression ISO RGD:732653 6480464 pirinixic acid results in decreased expression of EGLN3 mRNA CTD PMID:18445702 pirinixic acid increases expression ISO RGD:732653 6480464 pirinixic acid results in increased expression of EGLN3 mRNA CTD PMID:18301758 , PMID:23811191 potassium chromate increases expression ISO RGD:732652 6480464 potassium chromate(VI) results in increased expression of EGLN3 mRNA CTD PMID:22714537 potassium dichromate decreases expression ISO RGD:732653 6480464 Potassium Dichromate results in decreased expression of EGLN3 mRNA CTD PMID:23608068 progesterone increases expression EXP 6480464 Progesterone results in increased expression of EGLN3 mRNA CTD PMID:20726854 propiconazole decreases expression ISO RGD:732653 6480464 propiconazole results in decreased expression of EGLN3 mRNA CTD PMID:21278054 quercetin multiple interactions ISO RGD:732652 6480464 [Quercetin co-treated with Ascorbic Acid] results in increased expression of EGLN3 mRNA CTD PMID:17639512 raloxifene affects expression EXP 6480464 Raloxifene Hydrochloride affects the expression of EGLN3 mRNA CTD PMID:16079270 ranitidine multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of EGLN3 mRNA, Heparin inhibits the reaction [[Lipopolysaccharides co-treated with Ranitidine] results in increased expression of EGLN3 mRNA] CTD PMID:16401727 , PMID:16415329 reactive oxygen species multiple interactions ISO RGD:732652 6480464 [[Reactive Oxygen Species results in increased oxidation of dimethylselenide] which results in increased expression of DLGAP1-AS2 mRNA] which results in decreased expression of EGLN3 mRNA CTD PMID:33656867 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of EGLN3 mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:732652 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 , PMID:34480604 succimer multiple interactions ISO RGD:732653 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EGLN3 mRNA CTD PMID:26378955 sunitinib increases expression ISO RGD:732652 6480464 Sunitinib results in increased expression of EGLN3 mRNA CTD PMID:31533062 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of EGLN3 mRNA CTD PMID:21515302 testosterone decreases expression ISO RGD:732652 6480464 Testosterone results in decreased expression of EGLN3 mRNA CTD PMID:33359661 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of EGLN3 mRNA CTD PMID:31150632 tetrachloromethane decreases expression ISO RGD:732653 6480464 Carbon Tetrachloride results in decreased expression of EGLN3 mRNA CTD PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of EGLN3 mRNA] CTD PMID:31150632 theophylline multiple interactions ISO RGD:732652 6480464 [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of EGLN3 protein CTD PMID:18951874 thimerosal decreases expression ISO RGD:732652 6480464 Thimerosal results in decreased expression of EGLN3 mRNA CTD PMID:27188386 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of EGLN3 mRNA CTD PMID:23411599 titanium dioxide decreases expression ISO RGD:732653 6480464 titanium dioxide results in decreased expression of EGLN3 mRNA CTD PMID:23557971 trichloroethene increases methylation EXP 6480464 Trichloroethylene results in increased methylation of EGLN3 gene CTD PMID:27618143 trichostatin A decreases expression ISO RGD:732652 6480464 trichostatin A results in decreased expression of EGLN3 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:732652 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EGLN3 mRNA CTD PMID:27188386 triclosan increases expression ISO RGD:732652 6480464 Triclosan results in increased expression of EGLN3 mRNA CTD PMID:30510588 triphenyl phosphate increases expression EXP 6480464 triphenyl phosphate results in increased expression of EGLN3 mRNA CTD PMID:30589522 troglitazone decreases expression EXP 6480464 troglitazone results in decreased expression of EGLN3 mRNA CTD PMID:21515302 Tungsten carbide multiple interactions ISO RGD:732652 6480464 [tungsten carbide binds to Cobalt] which results in increased expression of EGLN3 mRNA, [tungsten carbide co-treated with Cobalt] results in increased expression of EGLN3 mRNA CTD PMID:18078969 , PMID:20105288 Tungsten carbide increases expression ISO RGD:732652 6480464 tungsten carbide results in increased expression of EGLN3 mRNA CTD PMID:20105288 urethane increases expression ISO RGD:732652 6480464 Urethane results in increased expression of EGLN3 mRNA CTD PMID:28818685 ursodeoxycholic acid decreases expression EXP 6480464 Ursodeoxycholic Acid results in decreased expression of EGLN3 mRNA CTD PMID:15885361 valproic acid decreases methylation ISO RGD:732652 6480464 Valproic Acid results in decreased methylation of EGLN3 gene CTD PMID:29154799 valproic acid multiple interactions ISO RGD:732652 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of EGLN3 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:732652 6480464 Valproic Acid results in decreased expression of EGLN3 mRNA CTD PMID:23179753 more ... valproic acid increases expression ISO RGD:732652 6480464 Valproic Acid results in increased expression of EGLN3 mRNA CTD PMID:23179753 more ... valproic acid affects expression ISO RGD:732652 6480464 Valproic Acid affects the expression of EGLN3 mRNA CTD PMID:25979313 vorinostat decreases expression ISO RGD:732652 6480464 vorinostat results in decreased expression of EGLN3 mRNA CTD PMID:27188386 XAV939 multiple interactions ISO RGD:732652 6480464 [[ascorbate-2-phosphate co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein] co-treated with [INHBA protein binds to INHBA protein]] results in decreased expression of EGLN3 mRNA, [[Ascorbic Acid co-treated with Chir 99021 co-treated with XAV939 co-treated with BMP4 protein co-treated with FGF1 protein co-treated with WNT3A protein co-treated with HGF protein] co-treated with [INHBA protein binds to INHBA protein]] results in increased expression of EGLN3 mRNA CTD PMID:34480604 zinc atom affects expression EXP 6480464 Zinc affects the expression of EGLN3 mRNA CTD PMID:16413754 zinc(0) affects expression EXP 6480464 Zinc affects the expression of EGLN3 mRNA CTD PMID:16413754